De Novo device
MATRx plus
Zephyr Sleep Technologies · Closed Loop Auto Titration Device For Oral Appliances (QCJ, Class II) · First FDA decision Aug 23, 2018, newest Aug 23, 2018Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
5
Naming "MATRx plus"
MAUDE reports
0
Brand "MATRx plus", since 2015
PubMed studies
0
Mentioning "MATRx plus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MATRx plus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MATRx plusNew device typeDe Novo
DEN170090 · Decided Aug 23, 2018 · 245 days after receipt
Device type: Closed Loop Auto Titration Device For Oral Appliances (QCJ) · Dentistry & Oral Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MATRx plus", any status and sponsor, newest update first.
- Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance TherapyCompleted
Zephyr Sleep TechnologiesNot on our public-company list
NCT03217383 · 75 participants · Start Jul 10, 2017 · Primary completion Mar 30, 2019
Device: MATRx plus · For: Sleep Apnea; Sleep Apnea, Obstructive; Sleep Disordered Breathing
Sites: Calgary, Canada
Zephyr Sleep TechnologiesNot on our public-company list
NCT03812692 · 59 participants · Start Feb 6, 2019 · Primary completion Mar 15, 2020
Device: MATRx plus · For: Obstructive Sleep Apnea
Sites: Calgary, Canada
- PSG Validation of MATRx Plus AHICompleted
Zephyr Sleep TechnologiesNot on our public-company list
NCT03627169 · 34 participants · Start Jul 25, 2017 · Primary completion Feb 1, 2018
Device: MATRx plus · For: Obstructive Sleep Apnea
Sites: Calgary, Canada
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MATRx plus", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QCJ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MATRx plus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.